Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Ocr	-	-	-	-	[1] 13 💬
2	Ocrelizumab	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[3] 13, 46, 49 💬
3	Ocrelizumab / rhumab 2h7	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
4	Ocrelizumab 300 mg	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
5	Ocrelizumab 300mg	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
6	Ocrelizumab 300mg /10ml	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
7	Ocrelizumab 300mg/10 ml	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
8	Ocrelizumab 300mg/10ml	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
9	Ocrelizumab 500mg	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
10	Ocrelizumab 600 mg	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
11	Ocrelizumab at home	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
12	Ocrelizumab dose 1	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
13	Ocrelizumab dose 2 and dose 3	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
14	Ocrelizumabu 200mg	-	-	-	-	[1] 46 💬
15	Ocrelizumabu 50mg	-	-	-	-	[1] 46 💬
16	Ocrevus	-	-	-	-	[1] 13 💬
17	Ocrrelizumab 300 mg	-	-	-	-	[1] 13 💬
18	Other: observation of ocrelizumab as treatment in rrms patients	Ocrelizumab	[1] D05218 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
19	Ovine corticotropin-releasing hormone (ocrh)	Corticorelin	[2] D00146, D03905 💬	[3] CRHR1, CRHR2, MC2R 💬	[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway	[1] 75 💬